- Home
- AVIR vs KINS Comparison
AVIR vs KINS Comparison
Compare AVIR & KINS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- KINS
- Stock Information
- Founded
- AVIR 2012
- KINS 1886
- Country
- AVIR United States
- KINS United States
- Employees
- AVIR N/A
- KINS N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- KINS Property-Casualty Insurers
- Sector
- AVIR Health Care
- KINS Finance
- Exchange
- AVIR Nasdaq
- KINS Nasdaq
- Market Cap
- AVIR 273.7M
- KINS 251.5M
- IPO Year
- AVIR 2020
- KINS N/A
- Fundamental
- Price
- AVIR $2.97
- KINS $16.30
- Analyst Decision
- AVIR Hold
- KINS Strong Buy
- Analyst Count
- AVIR 1
- KINS 1
- Target Price
- AVIR $6.00
- KINS $6.50
- AVG Volume (30 Days)
- AVIR 441.1K
- KINS 428.3K
- Earning Date
- AVIR 05-12-2025
- KINS 05-08-2025
- Dividend Yield
- AVIR N/A
- KINS N/A
- EPS Growth
- AVIR N/A
- KINS 5417.04
- EPS
- AVIR N/A
- KINS 1.60
- Revenue
- AVIR N/A
- KINS $169,875,701.00
- Revenue This Year
- AVIR N/A
- KINS $40.63
- Revenue Next Year
- AVIR N/A
- KINS $6.92
- P/E Ratio
- AVIR N/A
- KINS $10.21
- Revenue Growth
- AVIR N/A
- KINS 18.52
- 52 Week Low
- AVIR $2.46
- KINS $4.55
- 52 Week High
- AVIR $4.15
- KINS $22.40
- Technical
- Relative Strength Index (RSI)
- AVIR 56.05
- KINS 45.69
- Support Level
- AVIR $2.78
- KINS $15.63
- Resistance Level
- AVIR $3.03
- KINS $17.54
- Average True Range (ATR)
- AVIR 0.17
- KINS 1.09
- MACD
- AVIR 0.03
- KINS -0.18
- Stochastic Oscillator
- AVIR 88.03
- KINS 9.90
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About KINS Kingstone Companies Inc.
Kingstone Companies Inc is a multi-line regional property and casualty insurance holding company. It offers insurance policies to small and mid-sized businesses as well as to individuals.